Candel Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -14.33 | -100% |
| P/S |
|
1064.07 | 33.76 | 3052.11% |
|
|
| P/BV |
|
2.59 | 4.82 | -46.31% |
|
|
| P/FCF |
|
0 | 60.98 | -100% |
|
|
| Ev/Ebitda |
|
-0.5468 | -22.12 | -97.53% |
|
|
| Ev/S |
|
655.98 | 22.56 | 2807.28% |
|
|
| Ev/FCF |
|
-0.586 | 68.75 | -100.85% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-119970.97 | 4.83 | -2483782.51% | -40466.51 | 196.47% |
| ROE |
|
-297.68 | 9.61 | -3198.82% |
|
|
| ROA |
|
-90.98 | 0.3359 | -27183.94% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-122383.87 | -25.17 | 486126.89% |
|
|
| ROCE |
|
-301.22 | 15.33 | -2064.78% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5859 | -3.67 | -84.02% | -0.3433 | 70.67% |
| Nеt Debt/Ebitda |
|
0.3402 | -3.44 | -109.89% |
|
|
| Debt/Ratio |
|
0.5225 | 0.1972 | 165.02% |
|
|
| Debt/Equity |
|
0 | 1.65 | -100% |
|
|
| Debt/Net Income |
|
-0.5743 | 10.31 | -105.57% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-75.2 | -56.89 | 32.18% |
| Growth impulse Ebitda 5 years |
|
389.36 | -64.81 | -700.77% |
| Growth impulse Net Income 5 years |
|
374.24 | -58.33 | -741.59% |
| Growth impulse FCF 5 years |
|
554.74 | -47 | -1280.3% |
| Growth impulse EPS 5 years |
|
205.63 | -32.41 | -734.46% |
IP Score
4.26/10
